Clinical AI Governance Starts Below the Application Layer

Clinical AI governance is often described as a process for reviewing models, vendors, validation evidence, clinical workflow, privacy, and post-deployment monitoring. That is all necessary. It is also incomplete if the infrastructure below the application layer is treated as invisible.

An AI tool does not become clinically responsible because the vendor has a polished interface. It becomes safer to deploy when the health system understands where the data lives, how the tool is connected, who can access it, what is logged, what changes over time, how performance is monitored, and how the organization can pause, recover, or remove the system if risk changes.

The Application Is Only the Visible Layer

Clinicians and administrators usually experience AI through the application: an imaging worklist flag, a documentation draft, a risk score, a chatbot, a triage signal, or a workflow recommendation. The application is the visible layer. Governance has to look underneath it.

Below the application are the systems that make the AI workflow possible. That may include the EHR, PACS, RIS, claims systems, data warehouses, identity tools, network paths, storage systems, backup processes, observability tools, model-serving endpoints, integration engines, and older operational systems that still hold essential data.

If those dependencies are not documented, the AI governance committee is reviewing only part of the risk.

Data Locality Is a Governance Question

Data locality means knowing where the data is, where inference occurs, and why that location is appropriate. In clinical AI, data locality is not just a technical design preference. It affects privacy, latency, reliability, auditability, data minimization, and incident response.

A radiology AI tool, ambient documentation system, clinical decision support workflow, or claims-matching tool may each have a different acceptable pattern. Some workloads may run through cloud services. Others may need local processing or a hybrid design because the data is sensitive, the workflow is latency-sensitive, or the system of record remains inside a hospital-controlled environment.

The point is not that every clinical AI workload must run locally. The point is that data movement and inference location should be explicit decisions inside governance, not hidden assumptions inside procurement.

Infrastructure Evidence Supports Responsible Use

NIST's AI Risk Management Framework organizes AI risk work around Govern, Map, Measure, and Manage. CHAI's health AI governance playbooks give health systems practical domains for policy, organizational structures, lifecycle management, risk assessment, data management, third-party management, and education. Joint Commission's Responsible Use of AI in Healthcare certification focuses on governance, safeguards, monitoring processes, and education.

Those frameworks all depend on evidence. A health system cannot meaningfully manage AI risk if it cannot answer basic infrastructure questions:

• Which systems provide the data?
• Where does inference happen?
• Which users, services, or vendors can access the data?
• What logs are retained?
• How are model, application, and infrastructure changes tracked?
• What happens if the AI system fails during a clinical workflow?
• How does the organization recover if the connected system is unavailable?

Legacy Systems Are Part of the AI Map

Many healthcare organizations still rely on older administrative, financial, scheduling, supply chain, pharmacy, imaging, and claims-related systems. Some are modernized. Some are wrapped in newer interfaces. Some are still close to the operational core.

When AI adoption begins, those systems do not stop mattering. In some cases they become more important because the AI workflow depends on them for context. A governance map that includes only the new AI vendor and the EHR may miss the systems that actually determine data quality, availability, and business continuity.

This is why the IBM Power 11 and IBM i discussion matters in a clinical AI context. Not because every clinical AI tool should run on IBM infrastructure, but because many regulated organizations still have mission-critical operational data on durable platforms. If AI is moving closer to enterprise data, governance has to know where that data sits.

Operational Resilience Is Patient Safety Adjacent

Clinical AI governance should not treat uptime as a generic IT metric. If an AI-assisted workflow becomes part of triage, documentation, imaging prioritization, scheduling, patient routing, or operational decision-making, downtime can affect care delivery even when the AI tool itself is not making the final clinical decision.

That does not mean every outage is a patient safety event. It means the governance process should define dependency risk. If clinicians begin relying on a tool, the organization needs clear fallback workflows, downtime procedures, escalation paths, and monitoring triggers.

What Governance Should Require From the Infrastructure Layer

• System inventory. Identify every system that supplies data or receives AI output.
• Data-flow documentation. Show where data travels, where it is stored, and where inference occurs.
• Access control review. Define which users, vendors, applications, and service accounts can reach protected data.
• Logging and auditability. Retain enough evidence to review use, changes, errors, and incidents.
• Monitoring. Track system availability, workflow performance, model output behavior, and drift signals where applicable.
• Change management. Trigger re-review when the vendor, model, integration, data source, or infrastructure path changes.
• Recovery planning. Define fallback and recovery procedures before clinical dependence grows.

IBM Power 11 as an Infrastructure Signal

IBM's Power 11 direction is a useful market signal because it shows AI being built into the enterprise infrastructure layer, not only into front-end applications. Power 11 includes on-chip AI acceleration for inferencing, IBM Power Autonomous Operations adds AI-assisted system monitoring and remediation workflows, and IBM Bob Premium Package for i points toward AI-assisted modernization of IBM i applications.

For clinical AI governance, the lesson is broader than IBM. The infrastructure layer is becoming more intelligent, more automated, and more involved in AI operations. Governance should adapt by treating infrastructure as part of the AI lifecycle.

Related infrastructure context: AI-Ready Healthcare Infrastructure, Why Hospital AI Needs AI-Ready Infrastructure, Not Just AI Software, and IBM Power S1112 and Healthcare AI.

Practical Questions for Clinical AI Governance Teams

• Does the AI intake form require data-flow and infrastructure dependency documentation?
• Does the governance review include uptime, recovery, and fallback workflows?
• Are legacy systems included when they provide clinical, administrative, or claims context?
• Who owns logs and audit evidence after deployment?
• What infrastructure changes trigger re-review?
• Can the organization pause or isolate the AI workflow without breaking care delivery?
• How does post-deployment monitoring combine model, workflow, and system signals?

The Governance Takeaway

Clinical AI governance should start with patient safety, evidence, privacy, workflow, and accountability. But it should not stop there. The infrastructure below the application layer determines whether those governance commitments can be observed, audited, monitored, and enforced after the AI tool goes live.

The more clinical AI becomes part of normal care delivery, the more the infrastructure layer becomes part of clinical governance.

Reviewed: August 10, 2026. Next review: November 10, 2026.